The U.S. Food and Drug Administration has approved Onswik (insulin efsitora alfa-gobe), a long-acting insulin analog for adults with type 2 diabetes, to be used alongside diet and exercise for improved glycemic control. This approval marks Onswik as the second once-weekly insuli…
Pharmacogenomics explores how genetic variations can influence individual responses to medications, potentially enhancing treatment efficacy and safety. This field aims to reduce…
Lion's mane mushroom, known for its culinary and medicinal uses, is gaining attention for its potential health benefits. Recent research highlights its ability to support gut heal…
Vitruvias Therapeutics, Inc. has issued a nationwide recall of one lot of Thyroid Tablets, USP 30 mg due to confirmed testing that indicates the product may be super potent. This…
Fire and medical officials have raised concerns about the safety and efficacy of glutathione supplements offered to wildland firefighters exposed to toxic smoke. The supplement, w…
As hospitals report an increase in patients experiencing side effects from the unapproved weight-loss drug Retatrutide, health experts are raising alarms about its use. Despite no…
The FDA has granted accelerated approval for Genglycos, the first-ever therapy for patients aged 8 and older with glycogen storage disease type Ia (GSDIa). This gene therapy aims…
The emergence of GLP-1 weight loss drugs, such as Ozempic and Wegovy, has transformed the landscape of obesity treatment, generating significant revenue for manufacturers and spar…
A recent study conducted at Mbarara Regional Referral Hospital in Uganda found that over 60% of patients taking antipsychotic medications experienced at least one adverse drug rea…
A recent clinical trial at Boston Children's Hospital has explored the use of fecal microbiota transplants (FMT) to treat peanut allergies in adults. The study involved 15 partici…
The Health Products Regulatory Authority (HPRA) has confirmed over 1,500 reports of suspected adverse reactions related to anti-obesity medications, including serious gastrointest…
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorized orforglipron, making the UK the first country in Europe to approve this GLP-1 tablet for weight manag…
Kem skincare has introduced a revolutionary packaging suite that demands women navigate an intricate labyrinth of beauty obligations before even touching their cream.